Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Non-cash Items (2018 - 2023)

Historic Non-cash Items for Serina Therapeutics (SER) over the last 6 years, with Q4 2023 value amounting to $80000.0.

  • Serina Therapeutics' Non-cash Items rose 460588.24% to $80000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $80000.0, marking a year-over-year increase of 460588.24%. This contributed to the annual value of $80000.0 for FY2023, which is 460588.24% up from last year.
  • Serina Therapeutics' Non-cash Items amounted to $80000.0 in Q4 2023, which was up 460588.24% from $3.1 million recorded in Q3 2023.
  • In the past 5 years, Serina Therapeutics' Non-cash Items registered a high of $3.1 million during Q3 2023, and its lowest value of $1700.0 during Q4 2022.
  • Over the past 5 years, Serina Therapeutics' median Non-cash Items value was $1.9 million (recorded in 2020), while the average stood at $1.5 million.
  • Per our database at Business Quant, Serina Therapeutics' Non-cash Items plummeted by 9900.0% in 2019 and then surged by 460588.24% in 2023.
  • Over the past 5 years, Serina Therapeutics' Non-cash Items (Quarter) stood at $13000.0 in 2019, then skyrocketed by 1738.46% to $239000.0 in 2020, then plummeted by 55.23% to $107000.0 in 2021, then plummeted by 98.41% to $1700.0 in 2022, then surged by 4605.88% to $80000.0 in 2023.
  • Its Non-cash Items was $80000.0 in Q4 2023, compared to $3.1 million in Q3 2023 and $3.0 million in Q2 2023.